HUTCHMED (China) Limited
HMDCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -3.58 |
| FCF Yield | -1.47% | -1.47% | 0.43% | 0.36% |
| EV / EBITDA | 1,174.07 | 2,142.65 | -743.05 | -889.48 |
| Quality | ||||
| ROIC | -0.11% | -0.11% | -0.64% | -0.64% |
| Gross Margin | 39.65% | 39.65% | -17.36% | -17.36% |
| Cash Conversion Ratio | -0.16 | -0.16 | 3.38 | 3.38 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.35% | -3.80% | 6.15% | 6.48% |
| Free Cash Flow Growth | 0.00% | -352.77% | 0.00% | 165.09% |
| Safety | ||||
| Net Debt / EBITDA | -976.25 | -7.67 | 12.71 | 12.71 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 1.73 | 3.78 | 3.78 |
| Cash Conversion Cycle | 48.30 | 100.35 | 96.76 | 89.99 |